Background: Abdominal pain is one of the major symptoms of inflammatory Bowel
| INTRODUCTION
Abdominal pain/cramping is one of the major presenting symptoms of inflammatory bowel disease (IBD) patients experiencing onset or relapse of the disease. [1] [2] [3] [4] [5] Abdominal pain or fear of it is a significant burden in these patients that diminishes their quality of life. 5, 6 Visceral sensitivity to rectal distension, one of the factors contributing to the sensation of visceral pain, is increased in IBD patients. 7, 8 Visceral hy-
persensitivity (VHS) in response to colon inflammation is thought to
be caused by the actions of multiple inflammatory mediators acting on afferent neurons. [9] [10] [11] [12] [13] [14] However, not all IBD patients with active disease present with abdominal pain. 1, 15 On the other hand, it is not uncommon for some IBD patients to continue to have the symptom of abdominal pain during clinical and endoscopic remission, 15 which suggests that pathologic factors, such as sensitization of the spinal cord neurons and altered processing of the afferent signals in the CNS, may also contribute to abdominal pain in IBD patients independent of colon inflammation.
Little is known about potential contribution of spinal cord neurons in inducing visceral hypersensitivity in IBD patients. However, epidemiological studies suggest that exposure to postnatal and childhood infections are risk factors for the onset of IBD in later years, [16] [17] [18] [19] [20] and adult immune challenges by infectious gastroenteritis may trigger the onset of IBD, exacerbate the disease activity or relapse IBD during remission. [21] [22] [23] [24] These epidemiological findings have 
| METHODS

| Animals
All experimentation utilized male Sprague-Dawley rats. The
Institutional Animal Care and Use Committee at the University of
Texas Medical Branch at Galveston approved all procedures performed in this study. We did not include female rats due to lack of clear evidence for female bias in abdominal pain in IBD.
| Neonatal colon immune challenge
Ten-days-old neonatal rats received intraluminal colon infusion of trinitrobenzene sulfonic (TNBS) acid (130 mg/kg, dissolved in 0.2 mL saline containing 10% ethanol) to trigger immune challenge. The leakage of TNBS was prevented by holding the animals in trendelenburg position and holding the anus closed for one minute. The control rats received colonic infusion of saline only.
| Adult colonic inflammation
Eight-to twelve-weeks-old rats received intraluminal colonic infusion of TNBS (68 mg/kg, dissolved in 0.25 mL of 40% ethanol in water).
These animals received inhaled isoflurane anesthesia to receive TNBS infusion with anus held closed for 5 minutes. All experiments were performed 7 days after the infusion of TNBS.
| Spinal cord tissues
The spinal cord was expelled using hydrostatic pressure and the attached roots were removed. The spinal cord was cut at the center of the lumbar enlargement and segments caudal to this cut to the end of the cord constituted lumba-sacral spinal cord.
| Western blot
Western blot was performed as previously described. 25 Antibodies were used as follows: primary BDNF antibody (Santa Cruz Biotechnologies, Santa Cruz, CA, USA) at 1/200 dilution, β-actin antibody (Sigma Aldrich, St Louis, MO, USA) at 1/5000 dilution, beta-III tubulin antibody (Promega, Madison, WI, USA) at 1/1000. Secondary antibodies utilized were as follows: donkey antirabbit alexa fluor 680 (Invitrogen, Carlsbad, CA, USA) at 1/5000 dilution; goat antimouse IRDye 800 (Rockland, Pottstown, PA, USA) at 1/5000 dilution in PBS.
Li-cor Odyssey system (Li-Cor, Lincoln, NE, USA) was utilized to acquire images and measure band intensity. 
| Real-time RT-PCR
Key Points
• Treatment of visceral inflammatory pain remains unsatisfactory. The current focus is on identifying inflammatory mediators that induce visceral hypersensitivity.
• We found that epigenetic programming triggered by early-life colon inflammation upregulates spinal cord BDNF that aggravates visceral sensitivity when exposed to adult-life colon inflammation.
• Our findings suggest alternate approaches to manage visceral pain in IBD patients.
was calculated using the ΔΔCt method (Applied Biosystems, Foster City, CA, USA). 
| ChIP assays
| Visceromotor response to colorectal distention
Bipolar electrodes were sutured into the external oblique abdominal wall muscles of adult rats under inhaled 2% isoflurane anesthesia.
Electrode wires were routed subcutaneously and externalized in the subscapular region. Following at least 1 week of recovery from surgery, a 5 cm long balloon attached to a tygon tube was placed into the distal colon under 2% isoflurane anesthesia. The animals were confined in Lucite cubicles and allowed to adapt for at least 30 minutes prior to pneumatic colonic distention for 20 seconds followed by 2 minutes of rest at the following constant pressures: 20, 30, 40, 50, 60, and 80 mm Hg performed in duplicate, as previously described.
25
Electromyographic (EMG) activity was detected from the surgically implanted abdominal wall electrodes using Biopac MP100A and EMG100C amplifier (Biopac Systems, Inc., Santa Barbara, CA, USA).
The EMG signal was amplified, filtered at 300 Hz and digitized. The area under the curve (AUC) for the EMG signal during each 20 seconds of distention was calculated using Acknowledge software (Biopac Systems Inc., Goleta, CA, USA). The net value for each distension period was calculated by subtracting the baseline value derived from the average AUC for 20 seconds before and 20 seconds after the distention period. 25 This AUC (VxS) was plotted as a function of distention pressure. The area under this curve was calculated for each rat and used for statistical analyses. 
| Intrathecal infusions
| Plasma and cerebrospinal fluid norepinephrine measurements
Plasma and cerebrospinal fluid norepinephrine was measured by ELISA (Rocky Mountain Diagnostics, Colorado Springs, CO, USA).
| Locus ceruleus (LC) plugs
A 14 gauge tissue corer was used to remove plugs bilaterally from a 1.0 mm thick coronal section at Bregma −9.5 according to Rat Brain
Atlas by Watson and Paxinos.
| Laser capture micro-dissection
We injected CTB-488 (Invitrogen, Calsbad, CA, USA), 4 mg/mL in PBS, into the distal colon wall (six injections of 2 μL each/rat); ACI was induced 3 days later. S1 DRGs were collected 7 days later and frozen in OCT on dry ice. Twelve micron sections, prepared from both S1 
| Statistics
We utilized two-way ANOVA and subsequently compared individual means with Tukey post hoc analysis to determine the presence of significant differences among treatment groups of rats; P<.05 was considered statistically significant. Analyses were performed on Sigmaplot 12.0 (Systat software, San Jose, CA).
| RESULTS
| Neonatal colon inflammation is a risk factor for aggravating visceral hypersensitivity (VHS), when followed by adult colon inflammation
We investigated whether the upregulation of the visceromotor response to colorectal distention in response to adult colon inflammation is enhanced further in rats exposed previously to neonatal colon inflammation. We used four groups of rats (n=6 each group). Naïve adult control rats subjected to intraluminal colonic administration of saline (control rats); adult rats subjected previously to neonatal colon inflammation; adult naive rats subjected only to adult colon inflammation and rats subjected to neonatal colon inflammation followed by adult colon inflammation (neonatal/adult inflammation).
We found that the visceromotor response to colorectal distention in neonatal/adult inflammation rats was significantly greater than in adult colon inflammation rats (27%, P=.013), neonatal colon inflammation rats (46%, P=.001), and ctr. rats (65%, P<.001) ( Figure 1A ).
Adult colon inflammation alone produced a significant increase in the visceromotor response to colorectal distention vs control rats (30%, P=.03). There was no significant difference in the visceromotor response to colorectal distention in neonatal colon inflammation vs control rats (P=.33).
| Upregulation of spinal cord and dorsal root ganglia BDNF in neonatal/adult inflammation rats
We investigated whether upregulation of BDNF in the lumbar/sacral spinal cord underlies the aggravation of visceromotor response to colorectal distention in neonatal/adult inflammation rats. BDNF protein expression was significantly greater in neonatal/adult inflammation rats vs the adult colon inflammation rats (51%, P<.001),
control rats (160%, P<.001), and neonatal colon inflammation rats (100%, P<.001) ( Figure 1B ), n=6. BDNF expression in the lumbar/sacral spinal cord of adult colon inflammation rats was also significantly greater than that in control rats (73%, P<.001) ( Figure 1B ). There was F I G U R E 1 Enhanced visceromotor response to colorectal distention was observed in response to adult colon inflammation in adult rats subjected previously to neonatal colon inflammation. A, Graph showing the responses of control, neonatal colon inflammation, adult colon inflammation and neonatal/adult inflammation rats to graded colorectal distention, 7 days after initiation of adult colitis, n=6. We found significant effects of both neonatal colon inflammation (F 1,27 =6.84, P=.017) and adult colon inflammation (F 1,27 =19.4, P<.001) on visceral sensitivity. The visceromotor response to colorectal distention was significantly greater in neonatal/adult inflammation rats vs adult colon inflammation (*P=.013), neonatal colon inflammation alone (*P=.001) and control (*P<.001) rats. The visceromotor response to colorectal distention in adult colon inflammation rats was significantly greater in adult colon inflammation rats vs the control (#P=.03) rats. There was no significant difference in the visceromotor response to colorectal distention between neonatal colon inflammation and control rats. B, Western blot panels and bar graphs showing that BDNF protein expression in lumbar-sacral spinal cord segments was significantly higher in neonatal/ adult inflammation rats vs adult colon inflammation (*P<.001), control (*P<.001) and neonatal colon inflammation (*P<.001) rats. Spinal cord BDNF was also significantly greater in adult colon inflammation rats vs control rats (#P<.001, n=6). C, Graph showing BDNF mRNA expression in lumbar/sacral spinal cord segments normalized to 18S rRNA and expressed as fold change with respect to control BDNF mRNA was significantly upregulated in neonatal/adult inflammation vs adult colon inflammation (*P=.003), control (*P<.001) and neonatal colon inflammation (*P<.001) rats, and it was significantly upregulated in adult colon inflammation vs control (#P=.013) rats; significant effect of adult colon inflammation: Figure 1C ), There was no significant difference in BDNF mRNA expression between the control and neonatal colon inflammation rats (P=.54) ( Figure 1C ).
In colon projecting neurons from S1 dorsal root ganglia isolated by laser capture micro-dissection, BDNF mRNA was significantly upregulated in neonatal/adult inflammation vs adult colon inflammation rats (Figure 1D ), n=5 rats in each group. There were no significant differences between control and neonatal colon inflammation rats (P=.49) ( Figure 1D ). By contrast,
there was no significant difference in the expression of spinal cord nerve growth factor (NGF) between the neonatal/adult inflammation and adult colon inflammation rats (data not shown).
| Upregulation of spinal cord BDNF underlies the aggravation of visceromotor response to colorectal distention in neonatal/adult inflammation rats
Daily intrathecal injections of BDNF antagonist TrkB-Fc (5 μg in 10 μL sterile saline or vehicle twice/day) into the lumbar/sacral spinal cord for 7 days starting with the day of intraluminal administration of TNBS significantly suppressed the visceromotor response to colorectal distention to the level observed in control rats (P<.05, Figure 2 ).
| Upregulation of sympathetic activity contributes to aggravated VHS and BDNF upregulation in neonatal/adult inflammation rats
Clinical findings show an increase in sympathetic tone as measured by heart rate variability test in IBD patients. 26 We found that the Plasma norepinephrine levels were significantly increased in neonatal/adult inflammation vs adult colon inflammation rats (54%, P=.02), control rats (140%, P<.001), and neonatal colon inflammation rats (80%, P=.003) ( Figure 3A) . The plasma norepinephrine levels were also significantly greater in adult colon inflammation rats vs control rats (66%, P=.04) ( Figure 3A, n=10) .
The norepinephrine levels in the cerebrospinal fluid were significantly greater in neonatal/adult inflammation vs adult colon inflammation rats (36%, P=.019), control rats (58%, P<.001), and neonatal colon inflammation rats (63%, P<.001) ( Figure 3B ). There was no n=6-7( Figure 3D ).
Locus ceruleus is the primary source of norepinephrine in the brain. 27 The expression of tyrosine hydroxylase was significantly up- 
P<.001).
In addition, the CBP binding to CRE2 in adult colon inflammation rats was significantly greater than in control rats (2.5 fold,
P=.021) and neonatal colon inflammation rats (2.5 fold, P=.025), n=5
each group, ( Figure 5B ).
F I G U R E 3
Increased sympathetic activity contributes to enhanced visceral sensitivity in neonatal/adult inflammation rats. A, Graph showing plasma levels of norepinephrine 1 week after induction of adult colitis. We found significant main effects of neonatal colon inflammation We investigated whether the above epigenetic modulations underlie pro-transcriptional epigenetic changes at the BDNF core promoter.
We found that RNA polymerase II (RNAP II) Figure 6E ).
| DISCUSSION
Our findings show that robust neonatal colon immune challenge triggers epigenetic programming that upregulates tyrosine hydroxylase expression in the locus ceruleus, when these rats were subjected to a follow-up adult colon immune challenge. The upregulation of tyrosine hydroxylase elevates norepinephrine levels in the cerebrospinal fluid. Norepinephrine, acting on its adrenergic receptors is known to upregulate intracellular cAMP that activates protein kinase A (PKA). The catalytic subunit of PKA translocates to the nucleus to phosphorylate the transcription factor cAMP response element binding protein (CREB), which recruits CREB binding protein (CBP), a histone acetyl transferase (HAT) to the promoter to increase gene transcription. 28 We found that the increase of cerebrospinal fluid norepinephrine as well as the binding pCREB and rats. Overall, these findings suggest epigenetic-susceptibility to developing aggravated visceral sensitivity that contributes to abdominal pain. 7, 8 It is notable that neonatal colon inflammation by itself, had minimal effect on spinal cord BDNF expression or the visceromotor response to colorectal distention in later life, suggesting that the induction of intense visceral hypersensitivity is a two-step process; early-life colon immune challenge followed by a follow-up adult-life immune challenge. Our findings in a preclinical animal model consolidate the observations in two separate groups of epidemiological studies; one that in a subset of IBD patients, childhood immune challenge may be a risk factor for the development of IBD symptoms [16] [17] [18] [19] [20] ; and the other that adult immune challenge triggers the onset or relapse of IBD symptoms, including abdominal pain. [21] [22] [23] [24] Note that the epigenetic marks can be modified or erased by life styles and other environmental factors during adolescence and adult-life, 29 suggesting that 
H3K9 H4K12
not all subjects exposed to childhood immune challenges may develop epigenetic-susceptibility to developing IBD symptoms.
It is noteworthy that the specific type of epigenetic programming by adverse early-life experiences (AELE) and its target cells in organs depend on the type of stress, such as immune challenge, psychological stress and nutritional deficiency, severity and frequency of stress as well as on the timing of the stress during development, such as fetal, neonatal, and childhood. 25, 30 In this regard, our findings suggest that Hat inhibitors cross the blood-brain barrier to block the epigenetic upregulation of spinal cord BDNF in response to chronic prenatal stress. 25 Both, the cerebrospinal and plasma levels of norepinephrine, were upregulated in neonatal/adult inflammation rats vs the adult colonic inflammation rats. However, the peripheral norepinephrine does not cross the blood-brain barrier. 39 Therefore, it is unlikely that the increase of plasma norepinephrine contributed to the up- sympathetic tone than healthy controls as measured by heart rate variability.
26
IBD is a complex multi-organ and heterogeneous disease. There is no preclinical model that can completely simulate a complex human disease such as IBD. However, the preclinical models are used widely to mimic specific aspects of complex diseases, such as visceral hypersensitivity in our case, which is one of the prominent biomarkers of abdominal pain. The findings of these models can then be tested in human subjects by clinical studies and clinical trials. In our case, TNBSinduced colon inflammation is an established and widely used preclinical model of IBD and specifically of Crohn's disease because TNBS induces transmural inflammation.
41,42
In conclusion, neonatal immune challenge triggers epigenetic programming that upregulates tyrosine hydroxylase in the locus ceruleus, when these rats are exposed to a second immune challenge have not yet been related to a specific environmental factor or to the symptoms they may contribute to in IBD patients.
